182 related articles for article (PubMed ID: 9196188)
1. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
3. DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS.
Barchiesi F; Hollis RJ; McGough DA; Scalise G; Rinaldi MG; Pfaller MA
Clin Infect Dis; 1995 Mar; 20(3):634-40. PubMed ID: 7756488
[TBL] [Abstract][Full Text] [Related]
4. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
5. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.
Redding S; Smith J; Farinacci G; Rinaldi M; Fothergill A; Rhine-Chalberg J; Pfaller M
Clin Infect Dis; 1994 Feb; 18(2):240-2. PubMed ID: 8161633
[TBL] [Abstract][Full Text] [Related]
6. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
[TBL] [Abstract][Full Text] [Related]
7. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
9. Genetic dissimilarity of two fluconazole-resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient.
Berenguer J; Diaz-Guerra TM; Ruiz-Diez B; Bernaldo de Quiros JC; Rodriguez-Tudela JL; Martinez-Suarez JV
J Clin Microbiol; 1996 Jun; 34(6):1542-5. PubMed ID: 8735114
[TBL] [Abstract][Full Text] [Related]
10. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors.
Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C
Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316
[TBL] [Abstract][Full Text] [Related]
11. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
13. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient.
White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW
Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667
[TBL] [Abstract][Full Text] [Related]
14. Change in fluconazole susceptibility patterns and genetic relationship among oral Candida albicans isolates.
Diaz-Guerra TM; Martinez-Suarez JV; Laguna F; Valencia E; Rodriguez-Tudela JL
AIDS; 1998 Sep; 12(13):1601-10. PubMed ID: 9764778
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
16. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
17. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates.
Dromer F; Improvisi L; Dupont B; Eliaszewicz M; Pialoux G; Fournier S; Feuillie V
AIDS; 1997 Jul; 11(9):1095-101. PubMed ID: 9233455
[TBL] [Abstract][Full Text] [Related]
18. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
20. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
